Real-time enrollment status for this gynecologic cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 11:51 AM UTC
| NCT Number | NCT05758688 |
| Recruiting Status | Recruiting |
| Condition | Gynecologic Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 25 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Abramson Cancer Center at Penn Medicine |
| Last Updated on CT.gov | March 10, 2025 (Mar 10, 2025) |
As of March 2, 2026: Clinical trial NCT05758688 is currently recruiting participants. This clinical trial study for gynecologic cancer is actively seeking new participants at 3 locations across the United States. The study is sponsored by Abramson Cancer Center at Penn Medicine. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05758688 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05758688 was last updated Mar 10, 2025 (March 10, 2025). HelloStudys verifies this status automatically.